Cargando…
Deletion of AIF1 but not of YCA1/MCA1 protects Saccharomyces cerevisiae and Candida albicans cells from caspofungin-induced programmed cell death
Caspofungin was the first member of a new class of antifungals called echinocandins to be approved by a drug regulatory authority. Like the other echinocandins, caspofungin blocks the synthesis of β(1,3)-D-glucan of the fungal cell wall by inhibiting the enzyme, β(1,3)-D-glucan synthase. Loss of β(1...
Autores principales: | Chin, Christopher, Donaghey, Faith, Helming, Katherine, McCarthy, Morgan, Rogers, Stephen, Austriaco, Nicanor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348969/ https://www.ncbi.nlm.nih.gov/pubmed/28357223 http://dx.doi.org/10.15698/mic2014.01.119 |
Ejemplares similares
-
Filamentation protects Candida albicans from
amphotericin B-induced programmed cell death via a mechanism involving the yeast
metacaspase, MCA1
por: Laprade, David J., et al.
Publicado: (2016) -
Regulatory circuitry governing morphogenesis in Saccharomyces cerevisiae and Candida albicans
por: Shapiro, Rebecca S., et al.
Publicado: (2012) -
Management of a case of Candida albicans endogenous endophthalmitis with intravitreal caspofungin
por: Yadav, Harshali Manish, et al.
Publicado: (2017) -
Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
por: Victorio, Gerardo Becerra, et al.
Publicado: (2017) -
Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach
por: De Cesare, Giuseppe Buda, et al.
Publicado: (2022)